Project
Illumina Body Map 2 (GSE30611)
Navigation
Downloads
Results for KLF1
Z-value: 2.57
Motif logo
Transcription factors associated with KLF1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
KLF1
|
ENSG00000105610.6 | Kruppel like factor 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| KLF1 | hg38_v1_chr19_-_12887188_12887207 | 0.31 | 8.4e-02 | Click! |
Activity profile of KLF1 motif
Sorted Z-values of KLF1 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of KLF1
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.5 | 9.9 | GO:0030185 | nitric oxide transport(GO:0030185) |
| 1.9 | 5.7 | GO:1904692 | positive regulation of type B pancreatic cell proliferation(GO:1904692) |
| 1.3 | 4.0 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 1.3 | 5.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 1.0 | 3.1 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
| 1.0 | 2.9 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
| 0.9 | 2.7 | GO:0006147 | guanine catabolic process(GO:0006147) |
| 0.9 | 3.4 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.8 | 2.4 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 0.8 | 5.6 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 0.8 | 2.4 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.7 | 2.9 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
| 0.7 | 3.3 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.6 | 2.6 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
| 0.6 | 6.9 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.5 | 1.6 | GO:0035668 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.5 | 2.1 | GO:1900138 | negative regulation of phospholipase A2 activity(GO:1900138) |
| 0.5 | 4.1 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
| 0.5 | 3.6 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 0.5 | 2.5 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.5 | 2.0 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
| 0.5 | 1.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.5 | 2.8 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 0.4 | 1.3 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 0.4 | 5.9 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 0.4 | 2.5 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.4 | 1.6 | GO:0035498 | carnosine metabolic process(GO:0035498) |
| 0.4 | 1.6 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 0.4 | 1.1 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.4 | 4.1 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 0.4 | 2.2 | GO:0051620 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
| 0.4 | 3.5 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.3 | 1.0 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
| 0.3 | 2.0 | GO:1902164 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) platelet alpha granule organization(GO:0070889) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.3 | 5.7 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.3 | 1.3 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.3 | 1.3 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.3 | 1.3 | GO:0042710 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 0.3 | 2.6 | GO:0061709 | reticulophagy(GO:0061709) |
| 0.3 | 1.9 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
| 0.3 | 0.9 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.3 | 1.8 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.3 | 2.3 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.3 | 4.6 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
| 0.3 | 2.9 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 0.3 | 2.6 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.3 | 0.8 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.3 | 0.8 | GO:0030221 | basophil differentiation(GO:0030221) |
| 0.3 | 1.1 | GO:0097156 | fasciculation of sensory neuron axon(GO:0097155) fasciculation of motor neuron axon(GO:0097156) |
| 0.3 | 3.6 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.3 | 1.7 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.3 | 1.8 | GO:0010732 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 0.3 | 0.8 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 0.3 | 3.8 | GO:0030223 | neutrophil differentiation(GO:0030223) |
| 0.3 | 1.0 | GO:1902871 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 0.3 | 5.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.2 | 1.2 | GO:0030070 | insulin processing(GO:0030070) |
| 0.2 | 1.5 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.2 | 7.3 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.2 | 0.7 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.2 | 2.8 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.2 | 1.8 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.2 | 2.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.2 | 3.1 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.2 | 1.1 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.2 | 1.5 | GO:0021592 | fourth ventricle development(GO:0021592) |
| 0.2 | 2.0 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
| 0.2 | 2.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 0.2 | 2.8 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 0.2 | 0.7 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.2 | 4.8 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.2 | 0.5 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.2 | 1.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.2 | 2.8 | GO:1904896 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.2 | 1.7 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.2 | 3.9 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.2 | 8.1 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.2 | 2.7 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.2 | 0.5 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.2 | 2.0 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
| 0.2 | 1.5 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
| 0.2 | 2.3 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.1 | 0.7 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.1 | 0.9 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.1 | 4.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 | 0.8 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.1 | 1.9 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.1 | 0.7 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.1 | 2.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 | 6.4 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.1 | 1.3 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
| 0.1 | 3.5 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.1 | 0.9 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.1 | 1.0 | GO:0021816 | extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
| 0.1 | 1.7 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.1 | 3.3 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.1 | 1.4 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 | 0.9 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.1 | 0.6 | GO:1902896 | terminal web assembly(GO:1902896) |
| 0.1 | 3.3 | GO:2000674 | regulation of type B pancreatic cell apoptotic process(GO:2000674) negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.1 | 1.6 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.1 | 1.1 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.1 | 0.7 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.1 | 0.3 | GO:0071464 | cellular response to hydrostatic pressure(GO:0071464) |
| 0.1 | 1.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.1 | 0.5 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
| 0.1 | 1.0 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
| 0.1 | 1.3 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.1 | 10.3 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.1 | 0.2 | GO:1902688 | fermentation(GO:0006113) regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) |
| 0.1 | 1.6 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.1 | 0.2 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
| 0.1 | 0.5 | GO:0070842 | aggresome assembly(GO:0070842) |
| 0.1 | 0.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 | 0.5 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.1 | 1.2 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.1 | 0.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 | 0.5 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
| 0.1 | 0.6 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 0.1 | 0.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.1 | 0.9 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 | 1.8 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
| 0.1 | 6.4 | GO:0007019 | microtubule depolymerization(GO:0007019) |
| 0.1 | 1.8 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.1 | 1.3 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
| 0.1 | 0.5 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.1 | 0.9 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 | 0.3 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 | 0.6 | GO:0051511 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
| 0.1 | 2.1 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 0.1 | 7.0 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.1 | 4.9 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.1 | 2.9 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.1 | 0.7 | GO:0042048 | olfactory behavior(GO:0042048) |
| 0.1 | 2.0 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 | 0.5 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.1 | 0.3 | GO:0006272 | leading strand elongation(GO:0006272) |
| 0.1 | 1.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.1 | 1.4 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 | 0.6 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
| 0.1 | 1.9 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 | 0.9 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.1 | 0.8 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.1 | 0.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 | 0.8 | GO:0003096 | renal sodium ion transport(GO:0003096) |
| 0.1 | 0.5 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 | 0.3 | GO:0019542 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate biosynthetic process(GO:0019542) |
| 0.1 | 3.2 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.1 | 2.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
| 0.1 | 0.6 | GO:0071988 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 0.1 | 0.1 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.1 | 0.3 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 | 2.7 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 | 0.2 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 0.1 | 1.3 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.1 | 1.2 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.1 | 2.6 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.1 | 2.8 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.1 | 1.0 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.1 | 0.9 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.1 | 0.3 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.1 | 1.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 | 2.4 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.1 | 1.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.1 | 0.7 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 | 1.0 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.0 | 2.0 | GO:0030033 | microvillus assembly(GO:0030033) |
| 0.0 | 0.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 | 2.3 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 0.0 | 0.8 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.0 | 0.8 | GO:0015824 | proline transport(GO:0015824) |
| 0.0 | 2.2 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
| 0.0 | 0.3 | GO:0071504 | cellular response to heparin(GO:0071504) |
| 0.0 | 1.6 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.0 | 0.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.0 | 0.1 | GO:0021764 | amygdala development(GO:0021764) |
| 0.0 | 0.5 | GO:0001765 | membrane raft assembly(GO:0001765) |
| 0.0 | 1.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.0 | 2.4 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.0 | 0.5 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
| 0.0 | 1.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
| 0.0 | 0.5 | GO:1902572 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.0 | 1.8 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.0 | 2.4 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.0 | 1.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 | 1.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.0 | 0.3 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 0.0 | 0.5 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.0 | 0.3 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.0 | 0.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.0 | 0.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 | 0.4 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
| 0.0 | 0.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.0 | 2.2 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.0 | 1.4 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.0 | 0.2 | GO:0042748 | circadian sleep/wake cycle, non-REM sleep(GO:0042748) |
| 0.0 | 1.3 | GO:0035640 | exploration behavior(GO:0035640) |
| 0.0 | 1.4 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.0 | 1.0 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 | 2.2 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.0 | 1.3 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 | 0.1 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.0 | 0.2 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.0 | 0.3 | GO:2000795 | cell differentiation involved in salivary gland development(GO:0060689) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.0 | 0.8 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.0 | 0.3 | GO:0030091 | protein repair(GO:0030091) |
| 0.0 | 1.7 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.0 | 0.5 | GO:0006527 | citrulline metabolic process(GO:0000052) arginine catabolic process(GO:0006527) |
| 0.0 | 0.4 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.0 | 3.5 | GO:0006939 | smooth muscle contraction(GO:0006939) |
| 0.0 | 0.8 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.0 | 0.8 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.0 | 1.1 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
| 0.0 | 0.3 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.0 | 0.5 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
| 0.0 | 0.7 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.0 | 0.3 | GO:0015866 | ADP transport(GO:0015866) |
| 0.0 | 0.2 | GO:0019049 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) negative regulation of lung blood pressure(GO:0061767) |
| 0.0 | 1.5 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
| 0.0 | 0.6 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.0 | 2.3 | GO:0032418 | lysosome localization(GO:0032418) |
| 0.0 | 0.6 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 0.0 | 1.3 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
| 0.0 | 0.8 | GO:0051602 | response to electrical stimulus(GO:0051602) |
| 0.0 | 1.9 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.0 | 0.4 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.0 | 0.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.0 | 0.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 | 0.4 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
| 0.0 | 1.3 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
| 0.0 | 0.6 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.0 | 1.2 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
| 0.0 | 0.2 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
| 0.0 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.0 | 0.4 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
| 0.0 | 0.7 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.0 | 0.4 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.0 | 0.1 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.0 | 0.2 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
| 0.0 | 0.4 | GO:0061157 | mRNA destabilization(GO:0061157) |
| 0.0 | 1.8 | GO:0007187 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger(GO:0007187) |
| 0.0 | 0.3 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.0 | 0.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.5 | 9.9 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 0.9 | 2.8 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
| 0.7 | 5.6 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.6 | 3.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.4 | 1.9 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.4 | 4.0 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
| 0.3 | 1.3 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 0.3 | 1.3 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
| 0.3 | 8.3 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.3 | 2.3 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.2 | 2.0 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.2 | 1.3 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 0.2 | 1.5 | GO:0097513 | myosin II filament(GO:0097513) |
| 0.2 | 1.0 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.2 | 7.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.2 | 2.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.2 | 0.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.2 | 1.7 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 0.2 | 2.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.2 | 1.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.2 | 6.9 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.2 | 2.6 | GO:0005883 | neurofilament(GO:0005883) |
| 0.1 | 2.1 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.1 | 16.5 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.1 | 7.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.1 | 0.7 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.1 | 2.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.1 | 0.6 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.1 | 10.4 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.1 | 1.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.1 | 1.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.1 | 8.7 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.1 | 4.6 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.1 | 0.6 | GO:1990357 | terminal web(GO:1990357) |
| 0.1 | 0.4 | GO:0070701 | mucus layer(GO:0070701) |
| 0.1 | 3.1 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.1 | 0.8 | GO:0070695 | FHF complex(GO:0070695) |
| 0.1 | 1.3 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.1 | 0.5 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.1 | 7.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.1 | 3.8 | GO:0030057 | desmosome(GO:0030057) |
| 0.1 | 1.0 | GO:0008091 | spectrin(GO:0008091) |
| 0.1 | 2.5 | GO:0046930 | pore complex(GO:0046930) |
| 0.1 | 3.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.1 | 3.1 | GO:0043218 | compact myelin(GO:0043218) |
| 0.1 | 0.7 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 0.1 | 1.5 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.1 | 2.7 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.1 | 10.8 | GO:0005901 | caveola(GO:0005901) |
| 0.1 | 2.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 0.4 | GO:0044308 | axonal spine(GO:0044308) |
| 0.1 | 3.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.1 | 0.6 | GO:0055028 | cortical microtubule(GO:0055028) |
| 0.1 | 1.9 | GO:0005922 | connexon complex(GO:0005922) |
| 0.1 | 16.7 | GO:0008021 | synaptic vesicle(GO:0008021) |
| 0.1 | 1.8 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
| 0.1 | 6.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.1 | 1.3 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.1 | 0.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.1 | 0.4 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.0 | 0.8 | GO:0097450 | astrocyte end-foot(GO:0097450) glial limiting end-foot(GO:0097451) |
| 0.0 | 0.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.0 | 0.6 | GO:0072487 | MSL complex(GO:0072487) |
| 0.0 | 4.5 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
| 0.0 | 0.1 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 0.0 | 0.2 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.0 | 0.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.0 | 0.8 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.0 | 1.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.0 | 0.5 | GO:0030478 | actin cap(GO:0030478) |
| 0.0 | 7.2 | GO:0030426 | growth cone(GO:0030426) |
| 0.0 | 4.7 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.0 | 1.5 | GO:0043034 | costamere(GO:0043034) |
| 0.0 | 6.1 | GO:0044309 | neuron spine(GO:0044309) |
| 0.0 | 0.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.0 | 1.8 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.0 | 0.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.0 | 0.3 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.0 | 2.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.0 | 0.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.0 | 0.1 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
| 0.0 | 0.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.0 | 0.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.0 | 6.0 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.0 | 2.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.0 | 0.5 | GO:0005861 | troponin complex(GO:0005861) |
| 0.0 | 1.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.0 | 0.9 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.0 | 1.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 1.8 | GO:0045095 | keratin filament(GO:0045095) |
| 0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
| 0.0 | 0.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.0 | 0.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.0 | 0.1 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.0 | 3.0 | GO:0070820 | tertiary granule(GO:0070820) |
| 0.0 | 0.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.0 | 1.6 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.0 | 2.8 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.0 | 10.0 | GO:0010008 | endosome membrane(GO:0010008) |
| 0.0 | 0.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.0 | 7.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.0 | 0.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.0 | 2.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.0 | 0.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.0 | 0.4 | GO:0097060 | synaptic membrane(GO:0097060) |
| 0.0 | 2.3 | GO:0030496 | midbody(GO:0030496) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 9.9 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 1.4 | 5.6 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 1.0 | 3.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
| 0.9 | 2.7 | GO:0008892 | guanine deaminase activity(GO:0008892) |
| 0.9 | 3.6 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.8 | 2.3 | GO:0004108 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
| 0.7 | 5.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.7 | 2.8 | GO:0030395 | lactose binding(GO:0030395) |
| 0.6 | 1.8 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.6 | 5.9 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.4 | 7.3 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.4 | 5.5 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.4 | 1.6 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.4 | 5.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.4 | 1.9 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.4 | 2.2 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
| 0.4 | 3.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.4 | 1.8 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.3 | 6.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.3 | 1.3 | GO:0061714 | folic acid receptor activity(GO:0061714) |
| 0.3 | 0.9 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 0.3 | 3.4 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.3 | 1.5 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.3 | 1.2 | GO:0030379 | neurotensin receptor activity, non-G-protein coupled(GO:0030379) |
| 0.3 | 2.6 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.3 | 2.0 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 0.3 | 1.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.3 | 1.6 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.3 | 1.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.3 | 1.6 | GO:0035276 | ethanol binding(GO:0035276) |
| 0.3 | 1.6 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 0.3 | 1.9 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.3 | 2.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 0.3 | 3.3 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.2 | 1.5 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.2 | 1.7 | GO:0097001 | ceramide binding(GO:0097001) |
| 0.2 | 7.8 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.2 | 0.7 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
| 0.2 | 1.4 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 0.2 | 1.7 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.2 | 2.7 | GO:0015288 | porin activity(GO:0015288) |
| 0.2 | 2.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.2 | 0.8 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 0.2 | 0.8 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
| 0.2 | 18.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.2 | 2.5 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.2 | 1.3 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.2 | 4.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.2 | 0.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 0.2 | 3.6 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.2 | 4.0 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.2 | 1.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.2 | 1.7 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.2 | 12.5 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.2 | 0.5 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
| 0.2 | 0.5 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
| 0.2 | 4.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.1 | 1.8 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.1 | 2.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.1 | 2.4 | GO:0005113 | patched binding(GO:0005113) |
| 0.1 | 3.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.1 | 2.6 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
| 0.1 | 0.6 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 0.1 | 1.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.1 | 0.7 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.1 | 2.6 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.1 | 1.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.1 | 1.8 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.1 | 1.8 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.1 | 1.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.1 | 1.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.1 | 0.9 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 0.1 | 1.3 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.1 | 2.9 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.1 | 0.8 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.1 | 3.1 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.1 | 0.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.1 | 0.2 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.1 | 4.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.1 | 0.4 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 0.1 | 0.7 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.1 | 2.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) neuroligin family protein binding(GO:0097109) |
| 0.1 | 5.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.1 | 0.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.1 | 8.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.1 | 0.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.1 | 2.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.1 | 0.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.1 | 1.8 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.1 | 1.5 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.1 | 0.5 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.1 | 1.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.1 | 2.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.1 | 4.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.1 | 5.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.1 | 1.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.1 | 0.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.1 | 0.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.1 | 0.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.1 | 0.7 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.1 | 2.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.1 | 0.6 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.1 | 0.7 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.1 | 1.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.0 | 10.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.0 | 0.5 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.0 | 0.3 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.0 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.0 | 1.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.0 | 0.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.0 | 1.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.0 | 1.6 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.0 | 2.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.0 | 1.9 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.0 | 3.5 | GO:0070888 | E-box binding(GO:0070888) |
| 0.0 | 0.9 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.0 | 2.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.0 | 1.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.0 | 0.6 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 0.0 | 0.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.0 | 0.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.0 | 0.8 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.0 | 0.2 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
| 0.0 | 1.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.0 | 1.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.0 | 0.8 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 0.0 | 0.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.0 | 0.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.0 | 3.3 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 1.0 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.0 | 0.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.0 | 6.6 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.0 | 1.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.0 | 0.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.0 | 2.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.0 | 1.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.0 | 1.0 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.0 | 5.2 | GO:0002020 | protease binding(GO:0002020) |
| 0.0 | 0.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.0 | 3.6 | GO:0005178 | integrin binding(GO:0005178) |
| 0.0 | 4.4 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.0 | 1.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.0 | 6.7 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.0 | 2.8 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.0 | 0.7 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.0 | 1.7 | GO:0042379 | chemokine receptor binding(GO:0042379) |
| 0.0 | 0.3 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.0 | 0.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.0 | 0.8 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.0 | 0.5 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
| 0.0 | 0.2 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 0.0 | 2.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.0 | 0.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.0 | 0.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.0 | 0.5 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.0 | 1.6 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.0 | 0.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.0 | 1.6 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.0 | 8.6 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.0 | 0.8 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.0 | 0.9 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.0 | 1.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 2.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 0.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.0 | 0.6 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.0 | 0.9 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.0 | 4.7 | GO:0015631 | tubulin binding(GO:0015631) |
| 0.0 | 0.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.0 | 0.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.0 | 0.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.0 | 0.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.0 | 0.1 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.3 | 9.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.2 | 5.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.2 | 5.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 0.2 | 5.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.1 | 6.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.1 | 2.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.1 | 10.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.1 | 7.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.1 | 3.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.1 | 5.1 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.1 | 2.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 1.5 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.1 | 2.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.1 | 0.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.1 | 3.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.1 | 17.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 6.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.1 | 1.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.1 | 2.8 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.0 | 1.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.0 | 3.2 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.0 | 14.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 2.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.0 | 4.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.0 | 1.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.0 | 3.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.0 | 0.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.0 | 2.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.0 | 3.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.0 | 2.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.0 | 0.8 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.0 | 12.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.0 | 2.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 2.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.0 | 0.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.0 | 0.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.0 | 0.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.0 | 0.7 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.0 | 4.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 0.5 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
| 0.2 | 9.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.2 | 9.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
| 0.1 | 5.6 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 0.1 | 5.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.1 | 4.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.1 | 2.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.1 | 6.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 2.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.1 | 4.5 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.1 | 2.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.1 | 2.9 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
| 0.1 | 6.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.1 | 3.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.1 | 1.9 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
| 0.1 | 2.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.1 | 1.6 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.1 | 2.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.1 | 2.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.1 | 1.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.1 | 1.5 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.1 | 1.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.1 | 2.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.1 | 2.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.1 | 2.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.1 | 2.6 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.1 | 1.9 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.1 | 3.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.1 | 2.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 1.7 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.1 | 1.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.0 | 1.9 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.0 | 2.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.0 | 7.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.0 | 0.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.0 | 1.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.0 | 12.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.0 | 1.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.0 | 1.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.0 | 0.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.0 | 1.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.0 | 1.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.0 | 2.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 0.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.0 | 1.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 0.0 | 1.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.0 | 1.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.0 | 0.6 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.0 | 0.6 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.0 | 0.4 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
| 0.0 | 0.8 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.0 | 0.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.0 | 0.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.0 | 0.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.0 | 0.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.0 | 0.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.0 | 0.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |